Overview

Branched-chain Amino Acid (BCAA) on Progression of Advanced Liver Disease

Status:
Unknown status
Trial end date:
2018-06-01
Target enrollment:
Participant gender:
Summary
Protein-calorie malnutrition is frequently observed in patients with advanced liver cirrhosis. There have been continued interests in potential benefits of long-term oral branched-chain amino acid supplement in improving severity of liver disease. However, there are limited evidences in literature. The aim of this study is to evaluate the efficacy of oral branched-chain amino acid in patients with advanced liver cirrhosis.
Phase:
Phase 4
Details
Lead Sponsor:
Kyungpook National University
Kyungpook National University Hospital
Collaborator:
Samil Pharmaceutical Co., Ltd.